Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether imaging with 18F-choline PET/CT can provide
information that may help guide subsequent investigational or clinical treatments for
patients with advanced (hormone-refractory) metastatic prostate cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Queen's Medical Centre
Collaborators:
National Cancer Institute (NCI) National Institutes of Health (NIH)